Results 1 to 10 of about 743,600 (215)

Multireceptor fingerprints in progressive supranuclear palsy

open access: yesAlzheimer’s Research & Therapy, 2017
Background Progressive supranuclear palsy (PSP) with a frontal presentation, characterized by cognitive deficits and behavioral changes, has been recognized as an early clinical picture, distinct from the classical so-called Richardson and parkinsonism ...
Wang Zheng Chiu   +7 more
doaj   +1 more source

4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy

open access: yesNature Communications
Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by abnormal accumulation of the protein tau in the brain, leading to motor and cognitive symptoms that vary between individuals. The reasons for this clinical heterogeneity
Ivan Martinez-Valbuena   +21 more
doaj   +1 more source

A voxel based comparative analysis using magnetization transfer imaging and T1-weighted magnetic resonance imaging in progressive supranuclear palsy

open access: yesAnnals of Indian Academy of Neurology, 2014
Aims: In progressive supranuclear palsy (PSP) tissue damage occurs in specific cortical and subcortical regions. Voxel based analysis using T1-weighted images depict quantitative gray matter (GM) atrophy changes.
Mangalore Sandhya   +4 more
doaj   +1 more source

Progressive Supranuclear Palsy Syndrome: An Overview

open access: yesIBRO Neuroscience Reports
Progressive supranuclear palsy (PSP) is a neurodegenerative disease, commonly observed as a movement disorder in the group of parkinsonian diseases. The term PSP usually refers to PSP-Richardson’s syndrome (PSP-RS), the most typical clinical presentation.
Eduardo Ichikawa-Escamilla   +2 more
doaj   +1 more source

Challenges with the differential diagnosis of progressive supranuclear palsy and Parkinson’s disease

open access: yesАнналы клинической и экспериментальной неврологии, 2017
Progressive supranuclear palsy (PSP) is a severe old-age neurodegenerativedisease that is characterized by pronouncedclinical polymorphism and has different phenotypes.
R. V. Magzhanov   +5 more
doaj   +1 more source

Research on progressive supranuclear palsy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2011
DOI:10.3969/j.issn.1672-6731.2011.01 ...
Yiming LIU, Jiazhen LI
doaj  

Reversible drug-induced progressive supranuclear palsy-like presentation: A report of three cases

open access: yesAnnals of Movement Disorders, 2019
Drugs, such as dopamine receptor blockers or dopamine depleters, produce a functional dopamine-deficient state mimicking parkinsonism, but presentation with a progressive supranuclear palsy (PSP) is a rare manifestation.
Shivani Rath, Deepika Joshi
doaj   +1 more source

Early ophthalmologic manifestations of progressive supranuclear palsy: a case report with updated narrative literature review

open access: yesActa Marisiensis - Seria Medica
To highlight early ophthalmologic manifestations of progressive supranuclear palsy and emphasize their diagnostic value in clinic-radiological correlation and early disease recognition.
Yuananda Anak Agung Avrella Shora   +2 more
doaj   +1 more source

Imaging tau pathology in Parkinsonisms

open access: yesnpj Parkinson's Disease, 2017
The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that ...
Sarah Coakeley, Antonio P. Strafella
doaj   +1 more source

Home - About - Disclaimer - Privacy